UNH · UnitedHealth Group Incorporated

UnitedHealth Group delivered first quarter 2026 results with revenues of $111.7 billion, a 2% increase from $109.6 billion in the prior year quarter, driven by growth in UnitedHealthcare and Optum segments despite membership declines in certain areas. Earnings from operations dipped slightly to $9.0 billion from $9.1 billion, reflecting investments in people, technology, AI, and cybersecurity amid elevated medical costs. The medical care ratio improved 90 basis points to 83.9%, benefiting from strong cost management and favorable reserve development, including a 20 basis point positive from Optum Health loss contracts reserve, though offset by utilization trends. Operating cost ratio expanded to 13.8% from 12.4% due to strategic investments enhancing consumer/provider experiences and efficiencies. UnitedHealthcare revenues rose to $86.3 billion with operating margin expanding 40 basis points to 6.6%, supported by repricing amid elevated but expected cost trends; it served 49.1 million consumers. Optum generated $63.7 billion in revenues with $3.3 billion earnings at 5.2% margin; Optum Health adjusted earnings were $1.3 billion excluding prior reserves and restructuring. CEO Stephen Hemsley highlighted ongoing simplification and modernization efforts, including refocusing on U.S. healthcare by exiting non-U.S. businesses like Optum UK (sold with $400M proceeds to United Health Foundation), leadership refresh, AI investments, and governance enhancements such as a new Public Responsibility Committee. Strategic moves include acquiring Alegeus Technologies for consumer-directed accounts (earnings neutral, closing H2 2026) and $2 billion share repurchase by Q2 end. The company raised full-year 2026 outlook to over $17.35 GAAP EPS and $18.25 adjusted EPS, signaling confidence. Cash flows from operations were robust at $8.9 billion (1.4x net income), with debt-to-capital at 42.9% targeting 40% in H2 2026.